Xtant Medical XTNT Stock
Xtant Medical Price Chart
Xtant Medical XTNT Financial and Trading Overview
Xtant Medical stock price | 0.46 USD |
Previous Close | 0.69 USD |
Open | 0.66 USD |
Bid | 0 USD x 800 |
Ask | 0.75 USD x 1400 |
Day's Range | 0.64 - 0.69 USD |
52 Week Range | 0.43 - 1.2 USD |
Volume | 22.79K USD |
Avg. Volume | 14.69K USD |
Market Cap | 75.42M USD |
Beta (5Y Monthly) | 0.628521 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.12 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
XTNT Valuation Measures
Enterprise Value | 91.01M USD |
Trailing P/E | N/A |
Forward P/E | -17.315 |
PEG Ratio (5 yr expected) | -0.55 |
Price/Sales (ttm) | 1.1980695 |
Price/Book (mrq) | 2.3086667 |
Enterprise Value/Revenue | 1.446 |
Enterprise Value/EBITDA | -18.136 |
Trading Information
Xtant Medical Stock Price History
Beta (5Y Monthly) | 0.628521 |
52-Week Change | 40.81% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.2 USD |
52 Week Low | 0.43 USD |
50-Day Moving Average | 0.63 USD |
200-Day Moving Average | 0.67 USD |
XTNT Share Statistics
Avg. Volume (3 month) | 14.69K USD |
Avg. Daily Volume (10-Days) | 14.95K USD |
Shares Outstanding | 108.9M |
Float | 21.51M |
Short Ratio | 22.11 |
% Held by Insiders | 6.45% |
% Held by Institutions | 75.21% |
Shares Short | 191.84K |
Short % of Float | 1.28% |
Short % of Shares Outstanding | 0.18% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -13.26% |
Operating Margin (ttm) | -10.32% |
Gross Margin | 55.77% |
EBITDA Margin | -7.97% |
Management Effectiveness
Return on Assets (ttm) | -6.97% |
Return on Equity (ttm) | -26.93% |
Income Statement
Revenue (ttm) | 62.95M USD |
Revenue Per Share (ttm) | 0.63 USD |
Quarterly Revenue Growth (yoy) | 38.50% |
Gross Profit (ttm) | 32.14M USD |
EBITDA | -5018000 USD |
Net Income Avi to Common (ttm) | -8350000 USD |
Diluted EPS (ttm) | -0.09 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 5.18M USD |
Total Cash Per Share (mrq) | 0.05 USD |
Total Debt (mrq) | 21.59M USD |
Total Debt/Equity (mrq) | 66 USD |
Current Ratio (mrq) | 2.118 |
Book Value Per Share (mrq) | 0.3 |
Cash Flow Statement
Operating Cash Flow (ttm) | -6582000 USD |
Levered Free Cash Flow (ttm) | -6643000 USD |
Profile of Xtant Medical
Country | United States |
State | MT |
City | Belgrade |
Address | 664 Cruiser Lane |
ZIP | 59714 |
Phone | 406 388 0480 |
Website | https://www.xtantmedical.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 134 |
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Q&A For Xtant Medical Stock
What is a current XTNT stock price?
Xtant Medical XTNT stock price today per share is 0.46 USD.
How to purchase Xtant Medical stock?
You can buy XTNT shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xtant Medical?
The stock symbol or ticker of Xtant Medical is XTNT.
Which industry does the Xtant Medical company belong to?
The Xtant Medical industry is Medical Devices.
How many shares does Xtant Medical have in circulation?
The max supply of Xtant Medical shares is 139.05M.
What is Xtant Medical Price to Earnings Ratio (PE Ratio)?
Xtant Medical PE Ratio is now.
What was Xtant Medical earnings per share over the trailing 12 months (TTM)?
Xtant Medical EPS is -0.12 USD over the trailing 12 months.
Which sector does the Xtant Medical company belong to?
The Xtant Medical sector is Healthcare.